Alpha Tau Medical Ltd (DRTS)
2.41
-0.04
(-1.63%)
USD |
NASDAQ |
May 08, 16:00
2.48
+0.07
(+2.90%)
Pre-Market: 20:00
Alpha Tau Medical Enterprise Value: 91.73M for May 8, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 08, 2024 | 91.73M |
May 07, 2024 | 94.52M |
May 06, 2024 | 95.21M |
May 03, 2024 | 97.30M |
May 02, 2024 | 87.55M |
May 01, 2024 | 93.12M |
April 30, 2024 | 98.00M |
April 29, 2024 | 91.03M |
April 26, 2024 | 91.38M |
April 25, 2024 | 91.03M |
April 24, 2024 | 97.30M |
April 23, 2024 | 98.00M |
April 22, 2024 | 93.82M |
April 19, 2024 | 102.18M |
April 18, 2024 | 109.15M |
April 17, 2024 | 111.24M |
April 16, 2024 | 114.30M |
April 15, 2024 | 117.51M |
April 12, 2024 | 120.29M |
April 11, 2024 | 123.08M |
April 10, 2024 | 122.38M |
April 09, 2024 | 125.17M |
April 08, 2024 | 123.08M |
April 05, 2024 | 125.86M |
April 04, 2024 | 125.87M |
Date | Value |
---|---|
April 03, 2024 | 125.87M |
April 02, 2024 | 125.17M |
April 01, 2024 | 125.87M |
March 28, 2024 | 129.35M |
March 27, 2024 | 129.35M |
March 26, 2024 | 130.74M |
March 25, 2024 | 127.26M |
March 22, 2024 | 132.83M |
March 21, 2024 | 130.74M |
March 20, 2024 | 135.62M |
March 19, 2024 | 129.35M |
March 18, 2024 | 124.47M |
March 15, 2024 | 122.40M |
March 14, 2024 | 121.69M |
March 13, 2024 | 127.26M |
March 12, 2024 | 125.87M |
March 11, 2024 | 132.83M |
March 08, 2024 | 133.53M |
March 07, 2024 | 134.92M |
March 06, 2024 | 131.44M |
March 05, 2024 | 132.83M |
March 04, 2024 | 130.05M |
March 01, 2024 | 132.83M |
February 29, 2024 | 132.83M |
February 28, 2024 | 129.35M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
87.55M
Minimum
May 02 2024
986.58M
Maximum
Mar 29 2022
248.17M
Average
160.60M
Median
Enterprise Value Benchmarks
Taro Pharmaceutical Industries Ltd | 686.86M |
InspireMD Inc | 10.47M |
BiomX Inc | 16.63M |
Pluri Inc | 26.68M |
Holdco Nuvo Group DG Ltd | -- |
Enterprise Value Related Metrics
Net Income (Quarterly) | -7.365M |
Total Expenses (Quarterly) | 9.943M |
EPS Diluted (Quarterly) | -0.11 |
Earnings Yield | -17.43% |